Risk Prediction Models, Somatic Mutation Signatures, and Identifying Drivers of Carcinogenesis; Liquid Biopsy Integrated with Radiomics for Minimal Residual Disease Testing in High Risk Breast Cancer

Learning Objectives:

1. Understand new treatments in Hematology/Oncology

2. Discuss Current Research
3. Learn about new protocols

Session date:

10/12/2023 - 12:00pm to 1:00pm CDT

Add to calendar:

1.00 AMA PRA Category 1 Credit™
1.00 Participation

Please login or create an account to proceed.

Speaker Name:

Wenji Guo, MD PhD and Gideon Dosunmu, MD